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Background: Bovine viral diarrhoea (BVD) is an infectious disease of cattle with a worldwide distribution. Herd-level
prevalence varies among European Union (EU) member states, and prevalence information facilitates
decision-making and monitoring of progress in control and eradication programmes. The primary objective of the
present study was to address significant knowledge gaps regarding herd BVD seroprevalence (based on pooled
sera) and control on Irish farms, including vaccine usage.
Methods: Preliminary validation of an indirect BVD antibody ELISA test (Svanova, Biotech AB, Uppsala, Sweden)
using pooled sera was a novel and important aspect of the present study. Serum pools were constructed from
serum samples of known seropositivity and pools were analysed using the same test in laboratory replicates. The
output from this indirect ELISA was expressed as a percentage positivity (PP) value. Results were used to guide
selection of a proposed cut-off (PCO) PP. This indirect ELISA was applied to randomly constructed within-herd
serum pools, in a cross-sectional study of a stratified random sample of 1,171 Irish dairy and beef cow herds in
2009, for which vaccination status was determined by telephone survey. The herd-level prevalence of BVD in
Ireland (percentage positive herds) was estimated in non-vaccinating herds, where herds were classified positive
when herd pool result exceeded PCO PP. Vaccinated herds were excluded because of the potential impact of
vaccination on herd classification status. Comparison of herd-level classification was conducted in a subset of
111 non-vaccinating dairy herds using the same ELISA on bulk milk tank (BMT) samples. Associations between
possible risk factors (herd size (quartiles)) and herd-level prevalence were determined using chi-squared analysis.
Results: Receiver Operating Characteristics Analysis of replicate results in the preliminary validation study yielded
an optimal cut-off PP (Proposed Cut-off percentage positivity - PCO PP) of 7.58%. This PCO PP gave a relative
sensitivity (Se) and specificity (Sp) of 98.57% and 100% respectively, relative to the use of the ELISA on individual
sera, and was chosen as the optimal cut-off since it resulted in maximization of the prevalence independent
Youden’s Index.
The herd-level BVD prevalence in non-vaccinating herds was 98.7% (95% CI - 98.3-99.5%) in the cross-sectional
study with no significant difference between dairy and beef herds (98.3% vs 98.8%, respectively, p = 0.595).
An agreement of 95.4% was found on Kappa analysis of herd serological classification when bulk milk and serum
pool results were compared in non-vaccinating herds. 19.2 percent of farmers used BVDV vaccine; 81% of
vaccinated herds were dairy. A significant association was found between seroprevalence (quartiles) and herd size
(quartiles) (p< 0.01), though no association was found between herd size (quartiles) and herd-level classification
based on PCO (p = 0.548).
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Conclusions: The results from this study indicate that the true herd-level seroprevalence to Bovine Virus Diarrhoea
(BVD) virus in Ireland is approaching 100%. The results of the present study will assist with national policy
development, particularly with respect to the national BVD eradication programme which commenced recently.Background
Bovine viral diarrhoea (BVD) is an infectious disease of
cattle with a worldwide distribution [1]. In all countries
where data are available, herd-level antibody prevalence
to BVDV has averaged 55% [2]. An extensive review of
the epidemiology and of the economic importance of
BVDV is provided by Houe [3]. Transient infections in
seronegative immunocompetent cattle in most cases are
subclinical or result in mild signs including a transient
fever and leucopenia. Occasionally, young animals may
suffer from severe disease due to the immunosuppres-
sive effect of the virus resulting in super-infections by
opportunistic pathogens. The outcome of BVDV infec-
tion during pregnancy depends on the age of the fetus,
and may result in foetal resorption, abortion, mummifi-
cation, congenital malformations, birth of immunotoler-
ant persistently infected and viraemic calves or birth of
normal, weak or undersized calves [4]. Persistently
infected (PI) calves shed large quantities of virus while
having no or low levels of BVDV antibodies and can re-
main undetected in a herd or evolve to a highly fatal
clinical illness known as “Mucosal Disease” [5]. PIs are
the main source of viral transmission within herds [6],
and trade of PIs or non-PI dams carrying PI fetuses con-
stitutes the major route for the transmission of virus be-
tween herds [7]. Within-herd seroprevalence had varied
between 19 and 89% [8,9] while the prevalence of PI ani-
mals in the entire cattle population ranges from 0.5% to
2% [3,10-13]. A number of European countries are either
in advanced stages of eradication of BVD (Norway, Swe-
den, Denmark, Austria, Switzerland, Shetland (part of
the U.K.)) or implemented regional control programmes
(France, Germany, The Netherlands, Italy, U.K.). The con-
trol and eradication of BVD infections has been
reviewed previously [14,15].
In Ireland, some information has recently emerged on
BVD infection, albeit from a biased subset of Irish cattle
[16], indicating a herd-level prevalence of 94%. Individ-
ual animal seroprevalence was found to vary annually
between 64-69% over a sampling period of four years.
Seropositivity was significantly higher in adults com-
pared to juvenile stock. However, no data are available in
Ireland on the strategies used to control infection, in-
cluding vaccination. Significantly, as part of the national
Animal Health Ireland (AHI) initiative, a recent Delphi
study of experts and farmers identified BVD as among
the most important animal health issues facing Irish
livestock farmers, in terms of costs to farms andagribusiness [17]. Information regarding prevalence and
existing control measures facilitates decision-making
and monitoring of progress in control and eradication
programmes.
The primary objective of the present study was to de-
scribe BVD herd-level seroprevalence and vaccine usage
on dairy and beef farms in the Republic of Ireland. Pre-
liminary validation of an indirect BVD antibody ELISA
(Svanova; Biotech AB, Uppsala, Sweden) using pooled
sera was conducted as part of this study.
Methods
Preliminary validation
Five hundred negative and 500 positive sera (‘the
archived sera’) were selected from routine submissions
to the diagnostic unit of Agri-Food and Biosciences In-
stitute (AFBI) in Belfast. The archived sera were assayed
using an indirect ELISA for BVDV antibodies (Svanova;
Biotech AB, Uppsala, Sweden). These sera were classi-
fied into either of two groups – known BVDV antibody
test positives or test negatives. A validation pool was
classified positive if it contained ≥1 positive archived
serum sample. The test was performed according to the
instructions of the manufacturer. Both positive and
negative control sera were included in each assay. Sensi-
tivity (Se) and specificity (Sp) of the test when used on
individual sera relative to serum neutralisation test
(SNT) are 100% and 98.2%, respectively (Svanova, Data
on file). Only values for Se and Sp of the indirect ELISA
for BVDV antibody, when the test is used on individual
serum samples, are available (and not pool Se (PSe) and
pool Sp (PSp)) (Manufacturer data on file). We assume
PSe = Se and PSp = Sp.
The archived sera were used to form a series of valid-
ation pools, each containing 30 sera (20 μL each, 600 μL
for each sample pool). Specifically, each validation pool
included a defined number (‘n’) of positive sera (where
n= 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25 or 30) in com-
bination with 30-n negative samples. For example, one
validation pool had 0 positive and 30 negative samples,
another had 1 positive and 29 negative samples, etc. In
total, 90 validation pools were created, including 20
pools where n = 0, and 5 each for the 14 remaining posi-
tive/negative combinations. For each of these validation
pools, the positive and negative samples were each
selected using simple random sampling, using a com-
puter generated random number list (Microsoft Excel
2003, Redmond, WA, USA), from the 500 known
Table 2 Number of beef and dairy herds recruited within
each province
Province Herd type Total
Beef Dairy
Connaught 542 46 588
Leinster 434 175 609
Munster 474 449 923
Ulster 209 63 272
Total 1659 733 2392
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pools were analysed using the above-mentioned BVDV
antibody ELISA, all at AFBI’s diagnostic unit. The ab-
sorbance or optical density (OD) of each well at 450 nm
was measured on a microplate plate reader. The cor-
rected optical density (COD) value of each pool and
reference serum was obtained by subtraction of the OD
value of each control antigen-coated well from that of
the parallel viral antigen-coated well [18]. A correspond-
ing percentage positivity (PP) value was obtained using
the formula: PP value =COD (Sample)/COD (Positive
Control).Sample collection
Pooled serum
As part of the national statutory brucellosis eradication
scheme, serum samples are collected annually from all
eligible animals (female bovines and entire bulls aged
12 months or over) in all cattle herds in Ireland. A sam-
ple of these herds was selected for the current study.
Based on data available through the Animal Health
Computer System (AHCS), stratified random sampling
(based on two strata: ‘province’ and ‘herd size’) was used.
There are four provinces in Ireland (Connaught, Lein-
ster, Munster and Ulster). Two herd types were defined
in this study – beef (containing >66% beef breed cows)
and dairy (containing >66% dairy breed cows). The
number of animals sampled was proportional to the
number of herds with at least one birth registered in
2008 within each strata. In 2008, 87,396 herds had one
or more births registered. Of these, 2,037 were mixed
dairy and beef herds and were excluded. A further
30,894 herds were excluded because they were small
(dairy herds <20 breeding cattle; beef< 10 breeding cat-
tle). The proportion of the remaining 54,465 herds
within each strata is shown in Table 1. The aim was to
select a total sample size of 2,688 to allow for random
selection of sufficient herds stratified on herd type (beef
or dairy) and location (province) (Table 2). This sample
size was based on herd-level Se and Sp (calculated from
pooled-test Se and Sp values determined in theTable 1 Number of births registered, and number and percen
excluding mixed and small (dairy< 20 animals, beef< 10 ani
Province Animals
Beef Dairy Total Bee
Connaught 264,141 51,439 315,580 12,31
Leinster 300,933 254,292 555,225 9825
Munster 304,081 621,957 926,038 11,07
Ulster 106,809 73,675 180,484 4752
Total 975,964 1,001,363 1,977,327 37,97validation study) [19], a herd-level prevalence of 70%
based on a previous study [16] and a participation rate
of 50% for farms participating in the study during the
10 week collection period. Throughout the study period,
animals were mostly kept on managed grassland. While
2,688 were initially contacted, 296 herds had to be
excluded as they had either already completed their herd
test prior to the proposed collection period or their con-
tact details were inaccurate. Hence, 2392 herds were
recruited of which 1659 were classified beef (containing
<34% dairy breed cows) and 733 were dairy (>66% dairy
breed cows), with approximately 204,000 animals. These
farms represented just over 2% of all beef and dairy
herds in Ireland. These study inclusion criteria, taking
into account Irish national herd structure, would repre-
sent exclusion of less than 1% of dairy cows, but almost
15% of beef cows [20]. Permission for inclusion in the
study was sought from all selected herdowners.
Sample collection was conducted by private veterinary
practitioners (PVPs) during a ten-week period from May
to August 2009. The serum were placed in deep well
blocks and stored frozen. Samples were later thawed,
and a serum pool was generated for each herd, derived
from up to 30 individual sera (each 10 μL). In herds con-
taining <30 eligible animals, the pool included sera from
all animals; in herds containing >30 eligible animals, 30
sera were randomly selected based on a randomisation
list generated in Excel 2003. Sample pooling was carried
out in Enfer Diagnostics, Naas, Co. Kildare, Ireland, an
officially accredited laboratory. Testing of the serumtage of herds where a birth was registered, during 2008,
mals) herds, by province and herd type
Herds
Number %
f Dairy Total Beef Dairy Total
6 1032 13,348 22.6 1.9 24.5
3908 13,733 18.0 7.2 25.2
7 10,174 21,251 20.3 18.7 39.0
1381 6133 8.7 2.5 11.3
0 16,495 54,465 69.7 30.3 100.0
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mentioned indirect ELISA.
Bulk milk
120 dairy herds were selected using convenience sam-
pling for bulk milk analysis. Convenience sampling com-
prised contacting the owners of the first dairy herds
from which serum samples were collected and request-
ing that they submit a bulk milk sample from their herd.
Animals that contributed to the bulk milk sample
included all lactating animals contributing milk for pro-
cessing on the day of testing. In total, bulk milk was col-
lected from approximately 20% of all dairy herds from
which sera samples were obtained, within two weeks of
serum collection. Using a prepared protocol, each herd-
owner collected the bulk milk sample into a 20 mL uni-
versal container from an agitated bulk tank. Containers
contained bronopol preservative tablets and were posted
to AFBI for analysis using the above-mentioned indirect
BVDV antibody ELISA test, for the purposes of compari-
son with results from the sample serum pools.
Vaccine usage survey
A phone survey was used to clarify BVD vaccine usage
in each of the study herds. Each study herd owner was
contacted by phone by the first author, and an interview
was conducted regarding duration and timing of vaccin-
ation and brand of vaccine used. Where relevant, at least
three attempts were made to contact each study herd
keeper. National usage data were obtained from sales
data gathered by an industry survey [21]. GfK Kynetec is
an international market research company. Using Micro-
soft Excel 2003, the data were summarised according to
the number of vaccine doses sold by time of application
(month), and by location (county; 26 in 4 provinces
within the Republic of Ireland).
Data analysis
Preliminary validation
The PP values from each of the 90 validation pools was
recorded in a statistical software package (STATAW, Ver-
sion 11.0/SE (Stata Corporation, Texas, USA, 2009) and
subjected to Receiver Operator Characteristics (ROC)
analysis, to determine the optimal cut-off PP to
maximize Sp and Se of the test when used on pools [22].
Youden’s Index was calculated using the formula (Se +
Sp-1) [23]. However, only values for Se and Sp of the in-
direct ELISA for BVDV, when the test is used on indi-
vidual serum samples, are available (and not pool Se
(PSe) and pool Sp (PSp)) (Manufacturer data on file).
Vaccine usage
Among the study herds, vaccine usage by county, season-
ality and herd type were evaluated. Herds were classifiedas vaccinated within the previous 3 months, previous
6 months, previous year and non-vaccinated. Vaccine
usage in study herds was compared to national usage data.
Seroprevalence study
All of the following analyses were conducted on non-
vaccinated herds only.
Pooled serum
The optical density result of each serum pool was
recorded. The optimal cut-off PP value, as determined
during preliminary validation, was used to classify each
herd as seropositive or negative. Herd-level sensitivity
(HSe) and herd-level specificity (HSp) values for the in-
direct ELISA test, when PCO was applied to a single pool
of 30 samples from each herd, assuming a within-herd
prevalence of 75% [3], were calculated using formulas
derived previously [19]. Apparent (and true) herd-level
prevalence was calculated from the proportion of positive
pools using these HSe and HSp values. Associations be-
tween serum pool PP (quartiles) and herd type, herd size
and province were tested using a chi-square test, while
associations were also evaluated between herd-level sero-
prevalence classification (based on PCO) and the follow-
ing parameters: herd type, province and herd size
(quartiles) using a chi-square test.
ANOVA was conducted to determine associations be-
tween herd size and PP value of serum pools (quartiles).
The goodness-of-fit of the models was assessed by exam-
ining residuals. Herd size was categorized into quartiles.
Bulk milk
Bulk milk samples with PP ≥ 2.5 were deemed positive,
as per manufacturer recommendations. The statistical
software package: STATAW, Version 11.0/SE (Stata Cor-
poration, Texas, USA, 2009) was used to calculate
Cohen’s kappa coefficient, which is a measure of agree-
ment between the bulk milk results and the seropreva-
lence results. Herds that had a different result in the
bulk milk and seroprevalence studies were further inves-
tigated by whole herd analysis of individual serum sam-
ples to determine which classification was correct.
Results
Preliminary validation
There was good agreement between seropositive pools
and seropositivity (R2 = 0.87; Figure 1), and a significant
association between seropositivity and PP (p< 0.001).
Based on a Receiver Operating Characteristic analysis of
percentage positivity readings (PP), a cut-off PP of 2.12%
resulted in a Se and Sp of 100% and 95%, respectively,
relative to use of the ELISA on individual sera. A pro-
posed cut-off (PCO) PP of 7.58% gave a relative Se and
Sp of 98.57% and 100%, respectively. The PCO was
Figure 1 Comparison between percentage positivity (PP) and percentage of positive samples, based on 90 validation pools. A
polynomial line of best fit is included.
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pendent criterion (Youden Index) in order for the ELISA
to be used on bulk serum pools in the following sero-
prevalence study.Vaccine usage
Interviews were conducted with 1,113 (94.7% of the)
study herd owners. In total, 214 (19.2%) of these herds
had used BVD vaccine at some point, based on recall
from the herd owner. 81% of these 214 were dairy herds,
72% had commenced vaccination programmes within
the previous three years, 30% had been vaccinating for
less than 2 years, and 14% had begun to vaccinate within
the previous year.
Approximately 840,000 doses of BVD vaccine were
used in total by Irish farmers in 2009 [21], with a dis-
tinctly seasonal pattern of usage. Vaccination in this
study showed a similar seasonal pattern (Figure 2) to
overall vaccine usage in Ireland [21].Figure 2 Monthly BVD vaccine usage on 1,113 Irish farms and nationSeroprevalence study
Pooled serum
Sera from 1,175 of the 2392 recruited herds were col-
lected by 199 PVPs (approximately 61,000 sera from
60% of all bovine animals in these herds) during the
study period. Participation was largely influenced by the
decision of the herd-owner on the most suitable sea-
sonal timing of their brucellosis herd test, with the herd
owner of 1,217 herds choosing to delay until after
the collection period, mainly for commercial reasons.
450 of the collected herds contained 30 or less sam-
ples. Using the PCO determined in the validation
study, 13 herds were classified as seronegative. Exclud-
ing the 5.5% of herds where no vaccination history was
available, apparent herd-level prevalence was calculated
to be 98.9%. HSe and HSp were found to equate to
PSe and PSp using the formulae derived previously
[19]. Therefore true herd prevalence was calculated to
be 98.7% (95% CI – 97.9-99.4%) in non-vaccinating
herds.ally during 2009.
Table 3 % of herds in each province by serum pool
bovine viral diarrhoea (BVD) antibody ELISA Percentage







Connaught Leinster Munster Ulster Total
0-58 24.1 16.5 49.1 10.3 25.0
58-74 21.4 25.4 42.0 11.2 25.0
74-89 25.7 27.4 35.8 11.1 25.3
89-135 23.1 36.7 29.0 11.3 24.7
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known vaccination history and vaccinating herds
excluded) is outlined in Table 3. There was a significant
difference between provinces for herd-level PP quartiles
(p< 0.001), with highest PP values recorded in Leinster.
Herd-level prevalence classification based on PCO did
not differ significantly between dairy and beef herds
(98.3% vs 98.8%, respectively, p = 0.595). ANOVA showed
a significant association between herd size (quartiles) and
herd-level PP quartiles (p = 0.02). However, no associ-
ation was found on chi-square analysis of herd classifica-
tion based on PCO, by either province (p = 0.366), herd
type (p = 0.595) or herd size (quartiles) (p = 0.565).Bulk milk
In total, 111 bulk milk samples were collected from
herds, 41% of which were vaccinated. Herd-level preva-
lence in non-vaccinated herds was 92.3% (95% CI –
85.8-98.8%) based on results of bulk milk analysis. A
comparison of the results from the pooled serum and
bulk milk analyses of non-vaccinated herds, using the
two different cut-offs, is presented in Table 4. KappaTable 4 Bovine viral diarrhoea (BVD) herd status for 111
herds in Ireland during 2009 (based on a comparison of








(PP 2.12) (PP 7.58)
Negative Positive Negative Positive
Negative 1 4 2 3





The pooled serum results are separately presented at two different cut-off
percentage positivity (PP) values (2.12 and 7.58). The level of agreement in
BVD herd status, for non-vaccinated herds at each of the two cut-offs is
presented, using kappa statistics.analysis demonstrates 95.4% agreement between herd
classification of seroprevalence based on pooled serum
and bulk milk analysis when PCO is applied in non-
vaccinated herds. Misclassification occurred with 3 non-
vaccinating herds, using bulk milk analysis (at a cut-off
of PP>= 2.5) compared to pooled serum (at a cut-off of
PP = 7.58). In further evaluation conducted in 2 of the
three above-mentioned herds based on an analysis of
whole herd individual serum, both had been misclassi-
fied as negative using bulk milk analysis (two positive
animals in a herd of 141, four positive animals in a herd
of 42).
Discussion and conclusions
Apparent herd-level prevalence of BVD in non-
vaccinating herds in Ireland was 98.7% where herds were
classified positive when herd pool result exceeded PCO
PP. National herd-level seroprevalence expressed as a
percentage of positive herds depends on the cut-off se-
lection, which in turn depends on within-herd preva-
lence. Assuming a test sensitivity and specificity of 100%
and 98.2%, respectively, the true herd-level prevalence is
98.7% (95% CI:- 98.3-99.5%). Prevalence of BVD in this
study is higher than the 70% individual animal-level
seroprevalence estimated in previous studies [16]. How-
ever, assessment of animal-level BVD prevalence was
not a goal of this study. Ireland is imminently embarking
on an eradication programme and this study would yield
useful information on levels of exposure to BVD to allow
evaluation of progress. As this study is primarily con-
cerned with determining herd-level prevalence due to
disease exposure, including herd-level results from vac-
cinating herds could include herds where a positive anti-
body result was due to vaccination. Furthermore
vaccinated herds were excluded due to factors that could
have influenced the impact of vaccination on herd classi-
fication status. These include the variability of time be-
tween last vaccination and sampling on test result, the
variable status of vaccination within vaccinating herds
(part-herd vaccination, whole-herd vaccination), recall
bias and the recognised impact of vaccination on bulk
sample testing [6]. Prior to the present study, no infor-
mation was available on herd-level prevalence of BVD in
the Irish national herd, nor control measures implemen-
ted at farm level. Herd-level seroprevalence found in the
present study is somewhat higher than in other coun-
tries for which published data are available [1,3,24].
The preliminary validation study was carried out to
provide a proposed cut-off for use on serum pools of 30
samples. Two such cut-offs were found on ROC analysis
of the results and the higher cut-off (PCO) was chosen
based on maximization of the prevalence independent
criterion (Youden Index) as a conservative approach
to determining national herd-level seroprevalence.
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herd classification, than using the alternative cut-off
found on ROC analysis, when compared to results
obtained in the bulk milk study (Table 4). Pools in
the validation study were generated from a computer-
generated simple random combination of known nega-
tives and positives.
True herd-level seroprevalence of BVD can be deter-
mined from the number of seropositive pools [19]. The
effects of pooling on Se and Sp of tests have been evalu-
ated previously [19,25]. Epidemiological studies based on
pool sample testing (PST) are not recommended on eco-
nomic grounds if prevalence of disease is high [25].
However, PST will not give accurate assessment of
within-herd prevalence and the only question that can
be answered based on a single pooled sample per herd is
whether the herd is infected or not. As herd classifica-
tion is based on pooled tests in the seroprevalence study,
estimation of herd-level Se and herd-level Sp is more
complex because assumptions must be made about PSe
and PSp. In this study it was assumed PSe = Se and
PSp = Sp. It is likely that the PSe would be lower than Se
especially when within-herd prevalence is low and pool
size is large. The dilution effect on PSe will also be
dependent on the exposed animal's concentration of
antibody. In this study, one positive serum sample in the
pool (equivalent to 3% within-pool prevalence) was used
to determine cut-off in the ROC analysis. Furthermore,
within-herd prevalence based on previous seropreva-
lence studies may be in the range of 60-85%[3]. Individ-
ual animals remain seropositive for a relatively long time
after infection with maintained high levels of antibodies
[26]. It is therefore contended that any effect of pool size
on PSe would be mitigated by a combination of these
factors. Conversely, PSp should exceed Sp [19] because
dilution should make it less likely to have a false-positive
pooled test result than a false-positive individual-test
result.
Samples obtained from the last full national round of
statutory blood test screening for Brucella abortus pro-
vided a unique opportunity for conducting this study in
beef and dairy herds. It allowed an approach that would
normally be prohibitively labour-intensive, expensive
and dependent on issues arising from pooling sera. Sam-
pling bias by PVPs refusing to participate was minimised
by encouraging participation through clear communica-
tion of objectives to participating PVPs with a commit-
ment to provide herd-level results. Procedures were
implemented to ensure minimization of the effect of
cross-contamination. Cross reaction with other agents is
possible if a pool contained a viraemic animal. The
prevalence of PI animals was not determined in this
study. Cross-reacting agents could serve to lower the
estimated prevalence. However, as the prevalence in thisstudy is almost 100%, this factor is not envisaged as a
major confounding factor in prevalence estimation. Fur-
thermore, it has been suggested that pooling can reduce
the impact of cross-reaction due to the dilution of cross-
reacting agents with samples from non-infected animals
[19]. Few publications exist on the use of ELISA tests on
serum pools, though pools of 10 are widely used by the
AFSSA, France [27]. Up to 30 animals in each herd were
used in the serum pools in this study. A significant dif-
ference may have existed in certain herds, in terms of
sampled animals. Bulk milk samples included all adult
lactating females (except cows excluded due to illness,
treatment etc.) while serum pool analysis (98.2%) com-
prised 30 randomly selected animals from all female ani-
mals and breeding bulls >1 year from the same herds.
The impact of the difference in sampled animals was not
investigated in detail in this study. Kappa analysis
demonstrated 95.4% agreement between classification of
non-vaccinating herds based on bulk milk (92.3% posi-
tive) and classification based on serum pool analysis
(97.0% positive) when PCO was applied. Performance
characteristics of the test to detect antibodies in pooled
sera were demonstrated to exceed those in bulk milk by
whole herd analysis of individual animals carried out on
those herds misclassified as negative using the bulk milk
test compared to the analysis of pooled serum samples.
However, only two such herds were evaluated in this
study. Bulk milk, though widely used in seroprevalence
studies, limits the application to dairy herds, and low-
ered sensitivity of the ELISA has been identified in the
application of bulk milk analysis [28,29]. Bulk milk based
seroprevalence studies may also be influenced by timing
in seasonal calving populations and herd average yield
[30], although this is considered a minor issue. It is im-
portant to emphasise that the validation of the ELISA
test on serum pools was performed against the same
ELISA used on individual samples. While this is not op-
timal, as the Serum Neutralisation test is the accepted
gold standard test for validation, large quantities of
serum with known SNT readings were not available, as
many laboratories no longer routinely carry out this test
for a variety of reasons [31]. However, the ELISA has
been validated by the manufacturers against the SNT
when used on individual sera with a Se and Sp of 100%
and 98.2%, respectively. Larger-scale work is advised on
the use of serum pools with low seroprevalence to con-
firm the cut-off found in this study and to more accur-
ately validate the use of this test on serum pools. While
desirable for accurate estimation of national seropreva-
lence, analysis of all samples individually would obvi-
ously be prohibitively expensive.
The distinctly seasonal usage of BVD vaccine reflects
the calving pattern of the Irish herd, suggesting that
most vaccine is used prior to breeding as per
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cine is used in dairy herds (38% versus 9% of beef herds),
despite seroprevalence being equivalent in both herd
types. This suggests a significant information deficit in
the beef sector. Recall bias could have arisen in this
study among farmers surveyed. Vaccine brand used was
determined to minimize recall bias and confusion with
vaccines used to control other diseases.
Herd size was determined to be a significant risk fac-
tor with regard to pool PP (quartiles), however, no as-
sociation was found between this parameter and herd
classification based on PCO. This is likely to be be-
cause herd-level prevalence is almost 100%, which pre-
cludes differentiation between positive and negative
herds. Excluding herds where no vaccination history
was available, herd-level prevalence was 98.7% (95% CI
– 97.9-99.4%) in non-vaccinating herds. While vaccin-
ation affected individual animal prevalence in a previ-
ous study, a lack of a significant effect of vaccination
on herd-level prevalence was also found in that study
[32]. Herd level prevalence was only calculated in non-
vaccinating herds in this study. An association between
herd-level BVDV seroprevalence and herd size is in line
with previous findings [3], however, this may be a con-
founded risk factor [33].
BVD is widely recognized as a cause of a range of con-
ditions affecting a number of organ systems with the
outcome depending on immunocompetence [8]. Eco-
nomic losses from BVD infection have been reviewed
previously [34,35]. With a cattle population in Ireland
comprising 1.087 million dairy cows and 1.105 million
beef cows as well as growing animals [36]), and with
numbers of farms falling by 3-4% per year as average
farm size increases, significant disease control challenges
lie ahead. Current BVD controls have, until recently
been limited almost exclusively to vaccination, a strategy
which is unlikely to have a significant impact on national
herd-level prevalence [14]. Additional measures such as
identification and elimination of PI animals, certification
of herds and implementation of biosecurity measures
are required to make any impact on herd-level sero-
prevalence in Ireland considering the current high levels.
In addition to those EU member states already officially
free of disease, other countries (Netherlands, Belgium,
France, Germany, U.K., Spain and Italy among others)
are at various stages of herd certification/eradication
[27,37-40]. Knowledge of BVD seroprevalence is neces-
sary for designing and implementing effective concerted
national control and eradication measures. Animal
Health Ireland (AHI), an industry body charged with the
national leadership and coordination of production dis-
ease issues in Ireland, is currently assembling informa-
tion with a view to informing policy on their control.
AHI has implemented a voluntary scheme of PIelimination for calves born in Ireland since January 2012.
This approach is planned to become mandatory, through
legislative change, for all calves born in Ireland from
January 1st 2013. Furthermore, recent efforts by AHI and
other agencies to increase awareness of this disease and
encourage implementation of cost-effective controls, in-
cluding screening, elimination of PIs, vaccination and
biosecure practices will help reduce prevalence. However,
ultimately these must be coupled with a herd accredit-
ation programme and effective implementation of statu-
tory measures to reduce national prevalence.
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